Feline immunodeficiency virus | |
---|---|
![]() | |
Virus classification ![]() | |
(unranked): | Virus |
Realm: | Riboviria |
Kingdom: | Pararnavirae |
Phylum: | Artverviricota |
Class: | Revtraviricetes |
Order: | Ortervirales |
Family: | Retroviridae |
Genus: | Lentivirus |
Species: | Feline immunodeficiency virus |
Feline immunodeficiency virus (FIV) is a Lentivirus that affects cats worldwide, with 2.5% to 4.4% [1] [2] of felines being infected.
FIV was first isolated in 1986, by Niels C Pedersen and Janet K. Yamamoto at the UC Davis School of Veterinary Medicine in a colony of cats that had a high prevalence of opportunistic infections and degenerative conditions and was originally called Feline T-lymphotropic virus. [3] It has since been identified in domestic cats. [4] It has been suggested FIV originated in Africa and has since spread to feline species worldwide.
FIV compromises the immune system of cats by infecting many cell types, including CD4+ and CD8+ T lymphocytes, B lymphocytes, and macrophages. FIV can be tolerated well by cats, but can eventually lead to debilitation of the immune system in its feline hosts by the infection and exhaustion of T-helper (CD4+) cells.
FIV and HIV are both lentiviruses. However, humans cannot be infected by FIV, nor can cats be infected by HIV. FIV is transmitted primarily through deep bite wounds, where the virus present in the infected cat's saliva enters the body tissues of another cat. FIV-positive cats can share water bowls, food bowls (for both wet and dry cat food), and use the same litter box with low danger of transmitting the disease. A vigilant pet owner who treats secondary infections can allow an infected cat to live a reasonably long life. The chance that an FIV-infected cat will pass the virus to other cats within a household is low, unless there is fighting between cats, or wounds present that could allow entry of the virus from infected to non-infected cat.
Newborn kittens may test positive for up to six months and most thereafter will gradually test negative. It is thought that this is due to antibodies transferred to the kittens via the mother's milk. However these antibodies are transient so subsequent testing will be negative. Once they have received vaccinations against FIV, they will, in the future, always test positive, as the various blood tests detect and show the antibodies that have developed in response to the vaccination.
FIV is known in other feline species, and in fact is endemic in some large wild cats, such as African lions. Three main clades of FIV are recognized as of 2006, FIV-Ple (lion), FIV-Fca (domestic cat), and FIV-Pco (puma). [5] The host boundaries are usually well-kept due to the limited types of APOBEC3 enzymes viral infectivity factor can neutralize. [6]
![]() | The examples and perspective in this article deal primarily with the United States and do not represent a worldwide view of the subject.(January 2019) |
Consensus in the United States on whether there is a need to euthanize FIV-infected cats has not been established. The American Association of Feline Practitioners (an organization in the United States), as well as many feral cat organizations, recommends against euthanizing FIV-positive cats, or even spending funds to test for the virus. [7]
The virus gains entry to host cells through the interaction of its own envelope glycoproteins with the target cells' surface receptors. First, the SU glycoprotein binds to CD134, a receptor on the host cell. This initial binding changes the shape of the SU protein to one that facilitates interaction between SU and the chemokine receptor CXCR4. [8] This interaction causes the viral and cellular membranes to fuse, allowing the transfer of the viral RNA into the cytoplasm, where it is reverse transcribed and integrated into the cellular genome through nonhomologous recombination. Once integrated into the host cell's genome, the virus can lay dormant in the asymptomatic stage for extended periods of time without being detected by the immune system or can cause lysis of the cell. [9] [10]
CD134 is predominantly found on activated T cells and binds to OX40 ligand, causing T-cell stimulation, proliferation, activation, and apoptosis (3). This leads to a significant drop in cells that have critical roles in the immune system. Low levels of CD4+ and other affected immune system cells cause the cat to be susceptible to opportunistic diseases once the disease progresses to feline acquired immune deficiency syndrome (FAIDS). [11]
The primary mode of transmission is via deep bite wounds, in which the infected cat's saliva enters the other cat's tissues. FIV may also be transmitted from pregnant females to their offspring in utero; however, this vertical transmission is considered to be relatively rare, based on the small number of FIV-infected kittens and adolescents. [12] [11] This differs from FeLV, which may be spread by more casual, non-aggressive contact, such as mutual grooming and sharing of food bowls.[ citation needed ]
Risk factors for infection include male sex, adulthood, and outdoor access. One case study conducted in São Paulo found that 75% of FIV-infected cats were males. Higher rates of infection in males than females occurs due to biting being more frequently engaged in by males defending their territory. [10]
FIV progresses through similar stages to HIV. The initial stage, or acute phase, is accompanied by mild symptoms such as lethargy, anorexia, fever, and lymphadenopathy (swelling of the lymph nodes). [11] This initial stage is fairly short and is followed by the asymptomatic stage. Here the cat demonstrates no noticeable symptoms for a variable length of time. Some cats stay in this latent stage for only a few months, but for some it can last for years. Factors that influence the length of the asymptomatic stage include the pathogenicity of the infecting virus and FIV subtype (A–E), the age of the cat, and exposure to other pathogens. Finally, the cat progresses into the final stage (known as the feline acquired immune deficiency syndrome (FAIDS) stage), wherein the cat is extremely susceptible to secondary diseases that inevitably are the cause of death. [10]
Veterinarians will check a cat's history, look for clinical signs, and possibly administer a blood test for FIV antibodies. FIV affects 2–3% of cats in the US and testing is readily available. This testing identifies those cats that carry the FIV antibody but does not detect the actual virus.[ citation needed ]
"False positives" occur when the cat carries the antibody (which is harmless) but does not carry the virus. The most frequent occurrence of this is when kittens are tested after ingesting the antibodies from mother's milk (passive immunity), and when testing cats that have been previously vaccinated for FIV (active immunity). For this reason, neither kittens under eight weeks nor cats that have been previously vaccinated are tested. Kittens and young cats that test positive for the FIV antibody via passive immunity test negative later in life due to seroreversion, provided they have never been infected with FIV and have never been immunized with the FIV vaccine.[ citation needed ]
Cats that have been vaccinated will test positive for the FIV antibody for the rest of their lives owing to seroconversion, even though they are not infected. Therefore, testing of strays or adopted cats is inconclusive, since it is impossible to know whether or not they have been vaccinated in the past. For these reasons, a positive FIV antibody test by itself should never be used as a criterion for euthanasia. [13]
Tests can be performed in a vet's office with results in minutes, allowing for quick consultation. Early detection helps maintain the cat's health and prevents spreading infection to other cats. With proper care, infected cats can live long and healthy lives.[ citation needed ]
In 2006, the United States Department of Agriculture issued a conditional license for a new treatment aid termed Lymphocyte T-Cell Immunomodulator (LTCI). [14] Lymphocyte T-Cell Immunomodulator is manufactured and distributed exclusively by T-Cyte Therapeutics, Inc. [15]
Lymphocyte T-Cell Immunomodulator is intended as an aid in the treatment of cats infected with feline leukemia virus (FeLV) and/or feline immunodeficiency virus (FIV), and the associated symptoms of anemia (reduced oxygen-carrying ability in the blood), opportunistic infection, lymphocytopenia, granulocytopenia, or thrombocytopenia (low levels of lymphocytes, granulocytes, and platelets respectively, the first two are types of white blood cell). The absence of any observed adverse events in several animal species suggests that the product has a very low toxicity profile.[ citation needed ]
Lymphocyte T-Cell Immunomodulator is a potent regulator of CD-4 lymphocyte production and function. [16] It has been shown to increase lymphocyte numbers and Interleukin 2 production in animals. [17] It is a single-chain polypeptide and a strongly cationic glycoprotein, and is purified with cation exchange resin. Purification of protein from bovine-derived stromal cell supernatants produces a substantially homogeneous factor, free of extraneous materials. The bovine protein is homologous with other mammalian species and is a homogeneous 50 kDa glycoprotein with an isoelectric point of 6.5. The protein is prepared in a lyophilized (freeze-dried) 1 microgram dose. Reconstitution in sterile diluent produces a solution for subcutaneous injection.[ citation needed ]
As with HIV, the development of an effective vaccine against FIV is difficult because of the high number of, and differences between, variations of the virus strains. "Single-strain" vaccines, i.e., vaccines that only protect against a single virus variant, have already demonstrated a good efficacy against homologous FIV strains. A dual-subtype vaccine for FIV released in 2002 called Fel-O-Vax made it possible to immunize cats against more FIV strains. It was developed using inactivated isolates of two of the five FIV subtypes (or clades): A Petaluma and D Shizuoka. [18] The vaccine was shown to be moderately protective (82% of cats were protected) against subtype A FIV, [19] but a later study showed it to offer no protection against subtype A. [20] It has shown 100% effectiveness against two different subtype B FIV strains. [21] [22] Vaccination will cause cats to have positive results on FIV tests, making diagnosis more difficult. For these reasons the vaccine is considered "non-core", and the decision to vaccinate should be made after discussion with a veterinarian and consideration of the risks vs. the effectiveness. [23]
FIV displays a similar structure to the primate and ungulate lentiviruses. The virion has a diameter from 80 to 100 nanometers and is pleomorphic. The viral envelope also has surface projections that are small, 8 nm, and evenly cover the surface. [9]
The FIV virus genome is diploid. It consists of two identical single-strands of RNA in each case about 9400 nucleotides existing in plus-strand orientation. It has the typical genomic structure of retroviruses and includes LTR, vif, pol, gag, orfA, env, and rev genes. [24] [25] [26] The Gag polyprotein is cleaved into matrix (MA), capsid (CA) and nucleocapsid (NC) proteins. Cleavage between CA and NC releases a nine amino acid peptide, while cleavage at the C-terminus of NC releases a 2kDa fragment (p2). The Pol polyprotein is translated by ribosomal frame-shifting, a feature shared with HIV. Cleavage of Pol by the viral protease releases the protease itself (PR), reverse transcriptase (RT), deoxyuridine triphosphatase (dUTPase or DU) and integrase (IN). The Env polyprotein consists of a leader peptide (L), surface (SU) and transmembrane (TM) glycoproteins. In common with other lentiviruses, the FIV genome encodes additional short open reading frames (ORFs) encoding the Vif and Rev proteins. An additional short ORF termed orfA (also known as orf2) precedes the env gene. The function of OrfA in viral replication is unclear, however the orfA-encoded product may display many of the attributes of HIV-1 accessory gene products such as Vpr, Vpu or Nef.[ citation needed ]
Among these subtypes, genetic sequences are mostly conserved; however, wide-ranging genetic differences exist between species specific FIV subtypes. Of FIV's genome, Pol is the most conserved across FIV strains along with gag. On the contrary, env, vif, orfa, and rev are the least conserved and exhibit the most genetic diversity among FIV strains. [27]
The capsid protein derived from the polyprotein Gag is assembled into a viral core (the protein shell of a virus) and the matrix protein also derived from Gag forms a shell immediately inside of the lipid bilayer. The Env polyprotein encodes the surface glycoprotein (SU) and transmembrane glycoprotein (TM). Both SU and TM glycoproteins are heavily glycosylated, a characteristic that scientists believe may mask the B-cell epitopes of the Env glycoprotein giving the virus resistance to the virus neutralizing antibodies. [9]
Like HIV-1, FIV has been engineered into a viral vector for gene therapy. [28] Like other lentiviral vectors, FIV vectors integrate into the chromosome of the host cell, where it can generate long-term stable transgene expression. Furthermore, the vectors can be used on dividing and non-dividing cells. [28] [29] FIV vectors could potentially be used to treat neurological disorders like Parkinson's disease, and have already been used for transfer RNAi, which may find use as gene therapy for cancer. [30]
The exact origins and emergence of FIV in felids is unknown; however, studies of viral phylogenetics, felidae speciation, and FIV occurrence alludes to origins in Africa. Analysis of viral phylogenetics shows phylogenetic trees with a starburst phylogenetic pattern which is usually demonstrated by viruses that are a recent emergence with rapid evolution. [31] However, differences in topology, branch lengths, high genetic divergence suggest a more ancient origin in felidae species. Fossil records indicate extant felids arose from a common ancestor in Asia approximately 10.8 million years ago, and since then thirty eight species from eight distinct evolutionary lineages have spread and successfully inhabited every continent but Antarctica. [24] Despite felidae origins in Asia, FIV is absent from felidae species in Asia except for the Mongolian Pallas cat; however, FIV is highly endemic in Africa with four out of five felids having seropositive PCR results. [32] Due to the widespread occurrence and interspecies divergence of FIV strains in Africa, it's suggested that FIV arose in Africa before disseminating worldwide. The high genetic diversity and divergence between FIV strains in African felidae species and the presence of hyena FIV-Ccr, is consistent with a long residence time giving rise to increased opportunities for inter-species transmission among species. Additionally, lentiviruses are also highly endemic in Africa infecting not only felids, but also primates, and ungulate species. This suggests to the origins of all lentiviruses and supports FIV origins in Africa; however, further research is needed. [33] [34]
The spread of FIV from Africa might have occurred during two points of felidae migration. The earliest migration across the Bering Strait into North America occurred approximately 4.5 million years ago during a period of low sea levels. [35] Early felids in North America descended into seven species of the ocelot lineage, two species of the puma lineage, and four of the modern species of lynx. [36] The most recent migration of Asian lions and jaguars across Eurasia into North and South America occurred during the Pliocene/early Pleistocene. [35] These migrations events increased opportunities for FIV transmission among felids and established infections globally for felidae species.[ citation needed ]
Comparisons of FIV subtypes illustrate rapid evolution and highlights divergence in FIV strains. FIV-Pco, which is specific to American pumas, has two highly divergent subtypes. [37] Several studies have demonstrated subtypes A and B to have long branch lengths and low geographic similarities which indicates the possibility of two separate FIV introductions into populations coupled with a long residence time. [37] In the late Pleistocene, pumas fell victim to the ice age, went extinct in North America except for a small inbred population in Florida, and did not re-emerge until 10-12,000 years ago. [35] [38] Phylogenetic analysis of FIV-Pco strains in Central, South, and North America show Central and South American strains are more closely related to North American strains than to each other. [37] [39] This suggests FIV-Pco was already present in South American pumas which repopulated North America. [39] In African lions, FIV-Ple has diverged in to six subtypes A-F which exhibit distinct geographical endemicity to some degree. [40] Approximately 2 million years ago, African lions arose and dispersed throughout Africa, Asia, and North, Central, and South America. Modern lions currently reside only on the African continent except for a small population in India. [35] There is no documented disease association of FIV, but seroprevalence in free- ranging lion populations are estimated to be roughly 90%. [41] Phylogenetic analysis of FIV-Ple subtypes A, B, and C show high intra and interindividual genetic diversity and sequence divergence comparable to genetic differences to strains from other Felidae species. [25] These findings indicate these strains evolved in geographically distant lion populations; however, recent occurrences of these strains within populations in Serengeti National Park suggests recent convergence in the same population.[ citation needed ]
In domestic cats, FIV-Fca is pathogenic and can lead to feline AIDS symptoms and subsequent death. Phylogenetic analysis shows FIV to be a monophyletic branch that diverges into three subtypes A, B, and C. [27] Domestic cats arose more recently than other felidae species approximately around 10,000 years ago from a subspecies of wildcat Felis silvestris which inhabited East Asia. Genetic analysis indicates lower genetic diversity of FIV in the domestic cat compared to wild Felidae species, higher evolutionary rates, and higher mortality rates when compared to FIV-Ple and FIV-Pco. [42] This suggests the emergence of FIV in domestic cats was recent since newly emerged viruses tend to have higher evolutionary rates with little to no co-adaption between virus and new host species occurring. [27] Additionally, seroprevalence studies show companion cats to have a 4–12% occurrence while feral cats have an 8–19% prevalence which is much lower compared to wild felidae species which supports the hypothesis of FIV's recent emergence in this species. [43] [44]
FIV and feline leukemia virus (FeLV) are sometimes mistaken for one another though the viruses differ in many ways. Although they are both in the same retroviral subfamily (orthoretrovirinae), they are classified in different genera (FeLV is a gamma-retrovirus and FIV is a lentivirus like HIV-1). Their shapes are quite different: FeLV is more circular while FIV is elongated. The two viruses are also quite different genetically, and their protein coats differ in size and composition. Although many of the diseases caused by FeLV and FIV are similar, the specific ways in which they are caused actually differ. Also, while the feline leukemia virus may cause symptomatic illness in an infected cat, an FIV-infected cat can remain completely asymptomatic its entire lifetime.[ citation needed ]
The human immunodeficiency viruses (HIV) are two species of Lentivirus that infect humans. Over time, they cause acquired immunodeficiency syndrome (AIDS), a condition in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, the average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype.
An HIV vaccine is a potential vaccine that could be either a preventive vaccine or a therapeutic vaccine, which means it would either protect individuals from being infected with HIV or treat HIV-infected individuals.
Simian immunodeficiency virus (SIV) is a species of retrovirus that cause persistent infections in at least 45 species of non-human primates. Based on analysis of strains found in four species of monkeys from Bioko Island, which was isolated from the mainland by rising sea levels about 11,000 years ago, it has been concluded that SIV has been present in monkeys and apes for at least 32,000 years, and probably much longer.
Feline leukemia virus (FeLV) is a retrovirus that infects cats. FeLV can be transmitted from infected cats when the transfer of saliva or nasal secretions is involved. If not defeated by the animal's immune system, the virus weakens the cat's immune system, which can lead to diseases which can be lethal. Because FeLV is cat-to-cat contagious, FeLV+ cats should only live with other FeLV+ cats.
Carnivore protoparvovirus 1 is a species of parvovirus that infects carnivorans. It causes a highly contagious disease in both dogs and cats separately. The disease is generally divided into two major genogroups: FPV containing the classical feline panleukopenia virus (FPLV), and CPV-2 containing the canine parvovirus type 2 (CPV-2) which appeared in the 1970s.
Gammaretrovirus is a genus in the Retroviridae family. Example species are the murine leukemia virus and the feline leukemia virus. They cause various sarcomas, leukemias and immune deficiencies in mammals, reptiles and birds.
Following infection with HIV-1, the rate of clinical disease progression varies between individuals. Factors such as host susceptibility, genetics and immune function, health care and co-infections as well as viral genetic variability may affect the rate of progression to the point of needing to take medication in order not to develop AIDS.
The genome and proteins of HIV (human immunodeficiency virus) have been the subject of extensive research since the discovery of the virus in 1983. "In the search for the causative agent, it was initially believed that the virus was a form of the Human T-cell leukemia virus (HTLV), which was known at the time to affect the human immune system and cause certain leukemias. However, researchers at the Pasteur Institute in Paris isolated a previously unknown and genetically distinct retrovirus in patients with AIDS which was later named HIV." Each virion comprises a viral envelope and associated matrix enclosing a capsid, which itself encloses two copies of the single-stranded RNA genome and several enzymes. The discovery of the virus itself occurred two years following the report of the first major cases of AIDS-associated illnesses.
Envelope glycoprotein GP120 is a glycoprotein exposed on the surface of the HIV envelope. It was discovered by Professors Tun-Hou Lee and Myron "Max" Essex of the Harvard School of Public Health in 1984. The 120 in its name comes from its molecular weight of 120 kDa. Gp120 is essential for virus entry into cells as it plays a vital role in attachment to specific cell surface receptors. These receptors are DC-SIGN, Heparan Sulfate Proteoglycan and a specific interaction with the CD4 receptor, particularly on helper T-cells. Binding to CD4 induces the start of a cascade of conformational changes in gp120 and gp41 that lead to the fusion of the viral membrane with the host cell membrane. Binding to CD4 is mainly electrostatic although there are van der Waals interactions and hydrogen bonds.
Viral infectivity factor, or Vif, is an accessory protein found in HIV and other lentiviruses. Its role is to disrupt the antiviral activity of the human enzyme APOBEC by targeting it for ubiquitination and cellular degradation. APOBEC is a cytidine deaminase enzyme that mutates viral nucleic acids.
HIV tropism refers to the cell type in which the human immunodeficiency virus (HIV) infects and replicates. HIV tropism of a patient's virus is measured by the Trofile assay.
Feline calicivirus (FCV) is a virus of the family Caliciviridae that causes disease in cats. It is one of the two important viral causes of respiratory infection in cats, the other being Felid alphaherpesvirus 1. FCV can be isolated from about 50% of cats with upper respiratory infections. Cheetahs are the other species of the family Felidae known to become infected naturally.
HIV superinfection is a condition in which a person with an established human immunodeficiency virus infection acquires a second strain of HIV, often of a different subtype. These can form a recombinant strain that co-exists with the strain from the initial infection, as well from reinfection with a new virus strain, and may cause more rapid disease progression or carry multiple resistances to certain HIV medications.
Visna-maedi virus from the genus Lentivirus and subfamily Orthoretrovirinae, is a retrovirus that causes encephalitis and chronic pneumonitis in sheep. It is known as visna when found in the brain, and maedi when infecting the lungs. Lifelong, persistent infections in sheep occur in the lungs, lymph nodes, spleen, joints, central nervous system, and mammary glands; The condition is sometimes known as ovine progressive pneumonia (OPP), particularly in the United States, or Montana sheep disease. White blood cells of the monocyte/macrophage lineage are the main target of the virus.
Nef is a small 27-35 kDa myristoylated protein encoded by primate lentiviruses. These include Human Immunodeficiency Viruses and Simian Immunodeficiency Virus (SIV). Nef localizes primarily to the cytoplasm but also partially to the Plasma membrane (PM) and is one of many pathogen-expressed proteins, known as virulence factors, which function to manipulate the host's cellular machinery and thus allow infection, survival or replication of the pathogen. Nef stands for "Negative Factor" and although it is often considered indispensable for HIV-1 replication, in infected hosts the viral protein markedly elevates viral titers.
The primate T-lymphotropic viruses (PTLVs) are a group of retroviruses that infect primates, using their lymphocytes to reproduce. The ones that infect humans are known as human T-lymphotropic virus (HTLV), and the ones that infect Old World monkeys are called simian T-lymphotropic viruses (STLVs). PTLVs are named for their ability to cause adult T-cell leukemia/lymphoma, but in the case of HTLV-1 it can also cause a demyelinating disease called tropical spastic paraparesis. On the other hand, newer PTLVs are simply placed into the group by similarity and their connection to human disease remains unclear.
A neutralizing antibody (NAb) is an antibody that defends a cell from a pathogen or infectious particle by neutralizing any effect it has biologically. Neutralization renders the particle no longer infectious or pathogenic. Neutralizing antibodies are part of the humoral response of the adaptive immune system against viruses, intracellular bacteria and microbial toxin. By binding specifically to surface structures (antigen) on an infectious particle, neutralizing antibodies prevent the particle from interacting with its host cells it might infect and destroy.
MVA-B, or Modified Vaccinia Ankara B, is an HIV vaccine created to give immune resistance to infection by the human immunodeficiency virus. It was developed by a team of Spanish researchers at the Spanish National Research Council's Biotechnology National Centre headed by Dr. Mariano Esteban. The vaccine is based on the Modified vaccinia Ankara (MVA) virus used during the 1970s to help eradicate the smallpox virus. The B in the name "refers to HIV-B, the most common HIV subtype in Europe". It has been stated by Dr. Esteban that, in the future, the vaccine could potentially reduce the virulence of HIV to a "minor chronic infection akin to herpes".
SAV001-H is the first candidate preventive HIV vaccine using a killed or "dead" version of the HIV-1 virus.
Feline foamy virus or Feline syncytial virus is a retrovirus and belongs to the family Retroviridae and the subfamily Spumaretrovirinae. It shares the genus Felispumavirus with only Puma feline foamy virus. There has been controversy on whether FeFV is nonpathogenic as the virus is generally asymptomatic in affected cats and does not cause disease. However, some changes in kidney and lung tissue have been observed over time in cats affected with FeFV, which may or may not be directly affiliated. This virus is fairly common and infection rates gradually increase with a cat's age. Study results from antibody examinations and PCR analysis have shown that over 70% of felines over 9 years old were seropositive for Feline foamy virus. Viral infections are similar between male and female domesticated cats whereas in the wild, more feral females cats are affected with FeFV.